-
1
-
-
0344791653
-
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease
-
Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 594-600
-
-
Kielstein, J.T.1
Boger, R.H.2
Bode-Boger, S.M.3
Schaffer, J.4
Barbey, M.5
Koch, K.M.6
Frolich, J.C.7
-
2
-
-
0035936406
-
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
-
Zoccali C, Bode-Bö ger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frö lich J, Bö ger R: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117, 2001
-
(2001)
Lancet
, vol.358
, pp. 2113-2117
-
-
Zoccali, C.1
Bode-Bö ger, S.2
Mallamaci, F.3
Benedetto, F.4
Tripepi, G.5
Malatino, L.6
Cataliotti, A.7
Bellanuova, I.8
Fermo, I.9
Frö lich, J.10
Bö ger, R.11
-
3
-
-
0038583722
-
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure
-
Kielstein JT, Bode-Boger SM, Klein G, Graf S, Haller H, Fliser D: Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest 33: 370-375, 2003
-
(2003)
Eur J Clin Invest
, vol.33
, pp. 370-375
-
-
Kielstein, J.T.1
Bode-Boger, S.M.2
Klein, G.3
Graf, S.4
Haller, H.5
Fliser, D.6
-
4
-
-
33747186695
-
ADMA increases arterial stiffness and decreases cerebral blood flow in humans
-
Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J, Scalera F, Cooke JP, Fliser D, Bode-Boger SM: ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37: 2024-2029, 2006
-
(2006)
Stroke
, vol.37
, pp. 2024-2029
-
-
Kielstein, J.T.1
Donnerstag, F.2
Gasper, S.3
Menne, J.4
Kielstein, A.5
Martens-Lobenhoffer, J.6
Scalera, F.7
Cooke, J.P.8
Fliser, D.9
Bode-Boger, S.M.10
-
5
-
-
70450245459
-
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
-
Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C: Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Atherosclerosis 207: 541-545, 2009
-
(2009)
Atherosclerosis
, vol.207
, pp. 541-545
-
-
Aucella, F.1
Maas, R.2
Vigilante, M.3
Tripepi, G.4
Schwedhelm, E.5
Margaglione, M.6
Gesualdo, L.7
Boeger, R.8
Zoccali, C.9
-
6
-
-
77956407839
-
Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in predialysis patients with chronic kidney disease
-
Shi B, Ni Z, Zhou W, Yu Z, Gu L, Mou S, Fang W, Wang Q, Cao L, Yan Y, Qian J: Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in predialysis patients with chronic kidney disease. Eur J Intern Med 21: 444-448, 2010
-
(2010)
Eur J Intern Med
, vol.21
, pp. 444-448
-
-
Shi, B.1
Ni, Z.2
Zhou, W.3
Yu, Z.4
Gu, L.5
Mou, S.6
Fang, W.7
Wang, Q.8
Cao, L.9
Yan, Y.10
Qian, J.11
-
7
-
-
77957713880
-
Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study
-
Päivä H, Kähönen M, Lehtimäki T, Alfthan G, Viikari J, Laaksonen R, Hutri-Kähönen N, Laitinen T, Taittonen L, Raitakari OT, Juonala M: Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 212: 512-515, 2010
-
(2010)
Atherosclerosis
, vol.212
, pp. 512-515
-
-
Päivä, H.1
Kähönen, M.2
Lehtimäki, T.3
Alfthan, G.4
Viikari, J.5
Laaksonen, R.6
Hutri-Kähönen, N.7
Laitinen, T.8
Taittonen, L.9
Raitakari, O.T.10
Juonala, M.11
-
8
-
-
28444435118
-
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach
-
Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C: Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J Am Soc Nephrol 16: 2449-2455, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2449-2455
-
-
Ravani, P.1
Tripepi, G.2
Malberti, F.3
Testa, S.4
Mallamaci, F.5
Zoccali, C.6
-
9
-
-
27444444747
-
Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study
-
Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E: Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol 16: 2456-2461, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2456-2461
-
-
Fliser, D.1
Kronenberg, F.2
Kielstein, J.T.3
Morath, C.4
Bode-Boger, S.M.5
Haller, H.6
Ritz, E.7
-
10
-
-
77955904372
-
Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease
-
Wilson AM, Shin DS, Weatherby C, Harada RK, Ng MK, Nair N, Kielstein J, Cooke JP: Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease. Vasc Med 15: 267-274, 2010
-
(2010)
Vasc Med
, vol.15
, pp. 267-274
-
-
Wilson, A.M.1
Shin, D.S.2
Weatherby, C.3
Harada, R.K.4
Ng, M.K.5
Nair, N.6
Kielstein, J.7
Cooke, J.P.8
-
11
-
-
77952430963
-
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
-
Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, Frishman WH, Eng C, Pinsky DJ, Marmur JD: Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 210: 226-231, 2010
-
(2010)
Atherosclerosis
, vol.210
, pp. 226-231
-
-
Cavusoglu, E.1
Ruwende, C.2
Chopra, V.3
Poludasu, S.4
Yanamadala, S.5
Frishman, W.H.6
Eng, C.7
Pinsky, D.J.8
Marmur, J.D.9
-
12
-
-
70350057304
-
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality: An update on patient populations with a wide range of cardiovascular risk
-
Bö ger RH, Maas R, Schulze F, Schwedhelm E: Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality: An update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60: 481-487, 2009
-
(2009)
Pharmacol Res
, vol.60
, pp. 481-487
-
-
Bö ger, R.H.1
Maas, R.2
Schulze, F.3
Schwedhelm, E.4
-
13
-
-
67349279132
-
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population
-
Kiechl S, Lee T, Santer P, Thompson G, Tsimikas S, Egger G, Holt DW, Willeit J, Xu Q, Mayr M: Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis 205: 261-265, 2009
-
(2009)
Atherosclerosis
, vol.205
, pp. 261-265
-
-
Kiechl, S.1
Lee, T.2
Santer, P.3
Thompson, G.4
Tsimikas, S.5
Egger, G.6
Holt, D.W.7
Willeit, J.8
Xu, Q.9
Mayr, M.10
-
14
-
-
65249119330
-
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community
-
Bö ger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS: Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119: 1592-1600, 2009
-
(2009)
Circulation
, vol.119
, pp. 1592-1600
-
-
Bö ger, R.H.1
Sullivan, L.M.2
Schwedhelm, E.3
Wang, T.J.4
Maas, R.5
Benjamin, E.J.6
Schulze, F.7
Xanthakis, V.8
Benndorf, R.A.9
Vasan, R.S.10
-
15
-
-
56249115245
-
Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease
-
Kielstein JT, Zoccali C: Asymmetric dimethylarginine: A novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 17: 609-615, 2008
-
(2008)
Curr Opin Nephrol Hypertens
, vol.17
, pp. 609-615
-
-
Kielstein, J.T.1
Zoccali, C.2
-
16
-
-
0036315607
-
CREED Investigators. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
-
Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Bö ger R: CREED Investigators. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62: 339-345, 2002
-
(2002)
Kidney Int
, vol.62
, pp. 339-345
-
-
Zoccali, C.1
Mallamaci, F.2
Maas, R.3
Benedetto, F.A.4
Tripepi, G.5
Malatino, L.S.6
Cataliotti, A.7
Bellanuova, I.8
Bö ger, R.9
-
17
-
-
0036156916
-
CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
-
Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Bö ger R: CREED Investigators. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13: 490-496, 2002
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 490-496
-
-
Zoccali, C.1
Benedetto, F.A.2
Maas, R.3
Mallamaci, F.4
Tripepi, G.5
Malatino, L.S.6
Bö ger, R.7
-
18
-
-
0026548912
-
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
-
Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
-
(1992)
Lancet
, vol.339
, pp. 572-575
-
-
Vallance, P.1
Leone, A.2
Calver, A.3
Collier, J.4
Moncada, S.5
-
19
-
-
22844443807
-
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension
-
Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, Tripepi G, Sesti G, Zoccali C: Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46: 518-523, 2005
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 518-523
-
-
Perticone, F.1
Sciacqua, A.2
Maio, R.3
Perticone, M.4
Maas, R.5
Boger, R.H.6
Tripepi, G.7
Sesti, G.8
Zoccali, C.9
-
20
-
-
67349251188
-
Plasma asymmetric dimethylarginine, L-arginine, and left ventricular structure and function in a communitybased sample
-
Lieb W, Benndorf RA, Benjamin EJ, Sullivan LM, Maas R, Xanthakis V, Schwedhelm E, Aragam J, Schulze F, Bö ger RH, Vasan RS: Plasma asymmetric dimethylarginine, L-arginine, and left ventricular structure and function in a communitybased sample. Atherosclerosis 204: 282-287, 2009
-
(2009)
Atherosclerosis
, vol.204
, pp. 282-287
-
-
Lieb, W.1
Benndorf, R.A.2
Benjamin, E.J.3
Sullivan, L.M.4
Maas, R.5
Xanthakis, V.6
Schwedhelm, E.7
Aragam, J.8
Schulze, F.9
Bö ger, R.H.10
Vasan, R.S.11
-
21
-
-
68749084935
-
Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort
-
Maas R, Xanthakis V, Polak JF, Schwedhelm E, Sullivan LM, Benndorf R, Schulze F, Vasan RS, Wolf PA, Bö ger RH, Seshadri S: Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke 40: 2715-2719, 2009
-
(2009)
Stroke
, vol.40
, pp. 2715-2719
-
-
Maas, R.1
Xanthakis, V.2
Polak, J.F.3
Schwedhelm, E.4
Sullivan, L.M.5
Benndorf, R.6
Schulze, F.7
Vasan, R.S.8
Wolf, P.A.9
Bö ger, R.H.10
Seshadri, S.11
-
22
-
-
0037256204
-
Inflammation and atherosclerosis in end-stage renal disease
-
Zoccali C, Mallamaci F, Tripepi G: Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 21: 29-36, 2003
-
(2003)
Blood Purif
, vol.21
, pp. 29-36
-
-
Zoccali, C.1
Mallamaci, F.2
Tripepi, G.3
-
23
-
-
16244367738
-
IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia: The good, the bad, and the ugly
-
Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbü rger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia: The good, the bad, and the ugly. Kidney Int 67: 1216-1233, 2005
-
(2005)
Kidney Int
, vol.67
, pp. 1216-1233
-
-
Stenvinkel, P.1
Ketteler, M.2
Johnson, R.J.3
Lindholm, B.4
Pecoits-Filho, R.5
Riella, M.6
Heimbü rger, O.7
Cederholm, T.8
Girndt, M.9
-
24
-
-
34447120049
-
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes
-
Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner G: Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 30: 1834-1839, 2007
-
(2007)
Diabetes Care
, vol.30
, pp. 1834-1839
-
-
Krzyzanowska, K.1
Mittermayer, F.2
Wolzt, M.3
Schernthaner, G.4
-
25
-
-
23044456774
-
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
-
Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C: Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 67: 2330-2337, 2005
-
(2005)
Kidney Int
, vol.67
, pp. 2330-2337
-
-
Mallamaci, F.1
Tripepi, G.2
Cutrupi, S.3
Malatino, L.S.4
Zoccali, C.5
-
26
-
-
33750973371
-
Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients
-
Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, Kato A, Hishida A: Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis 48: 797-805, 2006
-
(2006)
Am J Kidney Dis
, vol.48
, pp. 797-805
-
-
Kumagai, H.1
Sakurai, M.2
Takita, T.3
Maruyama, Y.4
Uno, S.5
Ikegaya, N.6
Kato, A.7
Hishida, A.8
-
27
-
-
0032935896
-
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
-
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999
-
(1999)
Kidney Int
, vol.55
, pp. 648-658
-
-
Zimmermann, J.1
Herrlinger, S.2
Pruy, A.3
Metzger, T.4
Wanner, C.5
-
28
-
-
0034004568
-
C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
-
Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
-
(2000)
Am J Kidney Dis
, vol.35
, pp. 469-476
-
-
Yeun, J.Y.1
Levine, R.A.2
Mantadilok, V.3
Kaysen, G.A.4
-
29
-
-
0036406891
-
Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?
-
Stenvinkel P, Wanner C, Metzger T, Heimbü rger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 62: 1791-1798, 2002
-
(2002)
Kidney Int
, vol.62
, pp. 1791-1798
-
-
Stenvinkel, P.1
Wanner, C.2
Metzger, T.3
Heimbü rger, O.4
Mallamaci, F.5
Tripepi, G.6
Malatino, L.7
Zoccali, C.8
-
30
-
-
62349126160
-
The effect of joint exposures: Examining the presence of interaction
-
de Mutsert R, Jager KJ, Zoccali C, Dekker FW: The effect of joint exposures: examining the presence of interaction. Kidney Int 75: 677-681, 2009
-
(2009)
Kidney Int
, vol.75
, pp. 677-681
-
-
de Mutsert, R.1
Jager, K.J.2
Zoccali, C.3
Dekker, F.W.4
-
31
-
-
33747032266
-
ADMA, proteinuria, and insulin resistance in nondiabetic stage I chronic kidney disease
-
Caglar K, Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C: ADMA, proteinuria, and insulin resistance in nondiabetic stage I chronic kidney disease. Kidney Int 70: 781-787, 2006
-
(2006)
Kidney Int
, vol.70
, pp. 781-787
-
-
Caglar, K.1
Yilmaz, M.I.2
Sonmez, A.3
Cakir, E.4
Kaya, A.5
Acikel, C.6
Eyileten, T.7
Yenicesu, M.8
Oguz, Y.9
Bilgi, C.10
Oktenli, C.11
Vural, A.12
Zoccali, C.13
-
32
-
-
0347511748
-
Novel cardiovascular risk factors in end-stage renal disease
-
Zoccali C, Mallamaci F, Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 15[Suppl 1]: S77-S80, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, Issue.SUPPL. 1
-
-
Zoccali, C.1
Mallamaci, F.2
Tripepi, G.3
-
33
-
-
54949136493
-
Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): Is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
-
Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, Tapan S, Kucukardali Y, Sanisoglu YS, Solmazgul E, Sahan B, Sayan O: Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): Is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? J Rheumatol 35: 2024-2029, 2008
-
(2008)
J Rheumatol
, vol.35
, pp. 2024-2029
-
-
Terekeci, H.M.1
Oktenli, C.2
Ozgurtas, T.3
Nalbant, S.4
Top, C.5
Celik, S.6
Tapan, S.7
Kucukardali, Y.8
Sanisoglu, Y.S.9
Solmazgul, E.10
Sahan, B.11
Sayan, O.12
-
34
-
-
33847662338
-
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections
-
Zoccali C, Maas R, Cutrupi S, Pizzini P, Finocchiaro P, Cambareri F, Panuccio V, Martorano C, Schulze F, Enia G, Tripepi G, Boger R: Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 22: 801-806, 2007
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 801-806
-
-
Zoccali, C.1
Maas, R.2
Cutrupi, S.3
Pizzini, P.4
Finocchiaro, P.5
Cambareri, F.6
Panuccio, V.7
Martorano, C.8
Schulze, F.9
Enia, G.10
Tripepi, G.11
Boger, R.12
-
35
-
-
77952546772
-
ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: A cross-sectional study
-
Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E, Mihas C, Miliou A, Papademetriou V, Stefanadis C: ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: A cross-sectional study. Am J Kidney Dis 55: 1050-1059, 2010
-
(2010)
Am J Kidney Dis
, vol.55
, pp. 1050-1059
-
-
Tsioufis, C.1
Dimitriadis, K.2
Andrikou, E.3
Thomopoulos, C.4
Tsiachris, D.5
Stefanadi, E.6
Mihas, C.7
Miliou, A.8
Papademetriou, V.9
Stefanadis, C.10
-
36
-
-
36849035846
-
The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance
-
Konukoglu D, Firtina S, Serin O: The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 57: 110-115, 2008
-
(2008)
Metabolism
, vol.57
, pp. 110-115
-
-
Konukoglu, D.1
Firtina, S.2
Serin, O.3
-
37
-
-
74049159439
-
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases
-
Owczarek D, Cibor D, Mach T: Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) level in patients with inflammatory bowel diseases. Inflamm Bowel Dis 16: 52-57, 2010
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 52-57
-
-
Owczarek, D.1
Cibor, D.2
Mach, T.3
-
38
-
-
40149096187
-
Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C
-
Zhang GG, Bai YP, Chen MF, Shi RZ, Jiang DJ, Fu QM, Tan GS, Li YJ: Asymmetric dimethylarginine induces TNF-alpha production via ROS/NF-kappaB dependent pathway in human monocytic cells and the inhibitory effect of reinioside C. Vascul Pharmacol 48: 115-121, 2008
-
(2008)
Vascul Pharmacol
, vol.48
, pp. 115-121
-
-
Zhang, G.G.1
Bai, Y.P.2
Chen, M.F.3
Shi, R.Z.4
Jiang, D.J.5
Fu, Q.M.6
Tan, G.S.7
Li, Y.J.8
-
39
-
-
34548148963
-
Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II
-
Chen MF, Xie XM, Yang TL, Wang YJ, Zhang XH, Luo BL, Li YJ: Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. J Vasc Res 44: 391-402, 2007
-
(2007)
J Vasc Res
, vol.44
, pp. 391-402
-
-
Chen, M.F.1
Xie, X.M.2
Yang, T.L.3
Wang, Y.J.4
Zhang, X.H.5
Luo, B.L.6
Li, Y.J.7
-
40
-
-
63849163945
-
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
-
AURORA Study Group
-
Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wü thrich RP, Gottlow M, Johnsson E, Zannad F: AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360: 1395-1407, 2009
-
(2009)
N Engl J Med
, vol.360
, pp. 1395-1407
-
-
Fellström, B.C.1
Jardine, A.G.2
Schmieder, R.E.3
Holdaas, H.4
Bannister, K.5
Beutler, J.6
Chae, D.W.7
Chevaile, A.8
Cobbe, S.M.9
Grönhagen-Riska, C.10
de Lima, J.J.11
Lins, R.12
Mayer, G.13
McMahon, A.W.14
Parving, H.H.15
Remuzzi, G.16
Samuelsson, O.17
Sonkodi, S.18
Sci, D.19
Süleymanlar, G.20
Tsakiris, D.21
Tesar, V.22
Todorov, V.23
Wiecek, A.24
Wü thrich, R.P.25
Gottlow, M.26
Johnsson, E.27
Zannad, F.28
more..
-
41
-
-
3142606890
-
Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia
-
Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM: Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol 94: 157-161, 2004
-
(2004)
Am J Cardiol
, vol.94
, pp. 157-161
-
-
Lu, T.M.1
Ding, Y.A.2
Leu, H.B.3
Yin, W.H.4
Sheu, W.H.5
Chu, K.M.6
|